PMID: 17159598

Deeken JF, Figg WD, Bates SE, Sparreboom A
Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Anticancer Drugs. 2007 Feb;18(2):111-26., [PubMed]
Sentences
No. Mutations Sentence Comment
178 ABCG2 p.Cys55Ala
X
ABCG2 p.Cys55Ala 17159598:178:248
status: NEW
view ABCG2 p.Cys55Ala details
ABCB1 p.Gly449Ala
X
ABCB1 p.Gly449Ala 17159598:178:266
status: NEW
view ABCB1 p.Gly449Ala details
Table 5 Ethnic frequency (%) of allelic variants in CYP2C9 Allelic variant SNPs Caucasians African-Americans Asians Hispanics Africans CYP2C9*2 C430T 6.8-13.2 1.0-2.5 0 8.0 CYP2C9*3 A1075C 4.3-15.9 0.5-1.25 0-2.2 6.0 CYP2C9*5 C1080G 0 1.7 CYP2C9*7 C55A 7.1 CYP2C9*8 G449A 6.7 7.1 CYP2C9*9 A752G 0.5 13.3 14.3 CYP2C9*11 C1003T 1 CYP2C9*12 C1465T 0.5 SNP, single nucleotide polymorphism. Sources: Caucasians [51-54], African Americans [52,54,55], Asians [52,56], Hispanics [57], Africans [52]. Login to comment
326 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:326:59
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:326:39
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:326:81
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:326:106
status: VERIFIED
view ABCG2 p.Asn590Tyr details
These SNPs occur at mRNA positions 34 (V12M; exon 2), 421 (Q141K, exon 16), 616 (I206L, exon 6) and 1768 (N590Y, exon 15). Login to comment
328 ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:328:12
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:328:18
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:328:28
status: VERIFIED
view ABCG2 p.Asn590Tyr details
The SNPs of V12M, I206L and N590Y have not to date been found to confer an alteration in protein expression or function. Login to comment
329 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:329:99
status: VERIFIED
view ABCG2 p.Gln141Lys details
The nonsynonymous substitution C421A, in which a lysine is substituted for glutamine at codon 141 (Q141K), has been shown to have a functional significance. Login to comment
331 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:331:173
status: VERIFIED
view ABCG2 p.Gln141Lys details
ABCG2 p.Val12Met
X
ABCG2 p.Val12Met 17159598:331:153
status: VERIFIED
view ABCG2 p.Val12Met details
ABCG2 p.Ile206Leu
X
ABCG2 p.Ile206Leu 17159598:331:209
status: VERIFIED
view ABCG2 p.Ile206Leu details
ABCG2 p.Asn590Tyr
X
ABCG2 p.Asn590Tyr 17159598:331:226
status: VERIFIED
view ABCG2 p.Asn590Tyr details
Table 12 Ethnic frequencies (%) of allelic variants in ABCG2 gene Allelic variant Caucasians African-Americans Asians Hispanics Africans Middle Easterns V12M 2 4 20-45 40 5 Q141K 11-14 2.3-5.0 15-35 10 1.0 13 I206L 0 0 0 10 0 N590Y 1 Sources: [150-153]. Login to comment
334 ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 17159598:334:110
status: VERIFIED
view ABCG2 p.Gln141Lys details
Plasma concentrations of orally administered drugs, including oral topotecan, are higher in patients with the Q141K SNP, which correlates with the protein`s role in drug excretion. Login to comment